Tyson Foods Inc., a leading global meat processor, has announced it will remove the "No Antibiotics Ever" label from select chicken products, reintroducing antibiotics not significant to human treatment. This policy shift has raised eyebrows, given the growing concern about antibiotic resistance fueled by food production practices.
Tyson Foods ditched the drug for infections eight years ago, and since then, the “no antibiotics ever” has been emblazoned on its chicken products’ label packaging. Then again, only some of the chicken items are set to lose the mentioned phrase on the label.
According to CNN Business, the Springdale, Arkansas-based food processing company will start using antibiotics in its chicken production and said that this is the type that is not important to the treatment of humans. In any case, the use of antibiotics in food production or processing has been heavily scrutinized in recent years because some bacteria have become resistant to medicines and treatment due to repeated exposure to antibiotics.
“At Tyson Foods, we base our decisions on sound science and an evolving understanding of the best practices impacting our customers, consumers, and the animals in our care,” the spokesperson of Tyson Foods said in a statement.
The company said that some of its chicken would start deleting the “no antibiotics important to human medicine” on the label by the end of this year. Tyson Foods ascertained it would only apply antibiotics that are up to the standard and recognized by the USDA and the World Health Organization (WHO).
It was in 2015 when the company announced its decision to eliminate the antibiotics in its chicken wings, breast, and chicken nuggets. At the time, the company said it was working to get rid of the drug as it was worried about the increase in antibiotic-resistant bacterial infections in humans. It added that it would like to play its part in helping reduce the human consumption of antibiotics.
Meanwhile, The Wall Street Journal was the first to report on Tyson Foods’ decision to resume its use of non-medically important antibiotics in some of its chicken production. “Based on current science, Tyson brand products are transitioning to No Antibiotics Important to Human Medicine (NAIHM), which is expected to be complete by the end of the calendar year,” the company’s representative stated.


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Washington Post Publisher Will Lewis Steps Down After Layoffs
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



